Oxidant/Antioxidant Status in Men With Behcet's Disease

dc.contributor.author Taysi, Seyithan
dc.contributor.author Demircan, Berna
dc.contributor.author Akdeniz, Necmettin
dc.contributor.author Atasoy, Mustafa
dc.contributor.author Sari, Refik Ali
dc.date.accessioned 2025-05-10T17:07:33Z
dc.date.available 2025-05-10T17:07:33Z
dc.date.issued 2007
dc.description Atasoy, Mustafa/0000-0003-1904-9878 en_US
dc.description.abstract Behcet's disease (BD) is a chronic, progressive disorder that affects many systems of the body including the eye. The aim of this study was to assess whether the increase in oxidative stress in the affected tissues is reflected by lipid peroxidation and to check for alterations in antioxidants and antioxidant enzyme activities in patients with BD. Erythrocyte antioxidant potential (AOP), glutathione (GSH) and GSH-dependent enzymes (glutathione peroxidase (GSH-Px), glutathione reductase (GRD) and glutathione-S-transferase (GST), catalase (CAT), Cu-Zn superoxide dismutase (Cu-Zn SOD) activities, malondialdehyde (MDA) and some trace elements (zinc, Zn; copper, Cu; manganese, Mn) levels in men with BD. Erythrocyte CAT, GSH-Px activities, MDA, GSH, AOP and serum Zn values were significantly lower in patients with BD than in the control group. However, erythrocyte Cu-Zn SOD, GRD activities, erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP) and Cu values were significantly higher in patients with BD than in the control group, but GST activity and serum Mn values were unchanged. In conclusion, our results confirm the presence of oxidative stress in patients with BD and suggest that the severity of BD may arise from impaired antioxidant mechanisms. Therapy with antioxidants may lead to the increase in the antioxidant defense system and thus improvement in clinical symptoms. en_US
dc.identifier.doi 10.1007/s10067-006-0513-x
dc.identifier.issn 0770-3198
dc.identifier.issn 1434-9949
dc.identifier.scopus 2-s2.0-33947680233
dc.identifier.uri https://doi.org/10.1007/s10067-006-0513-x
dc.identifier.uri https://hdl.handle.net/20.500.14720/6804
dc.language.iso en en_US
dc.publisher Springer London Ltd en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Antioxidant Enzymes en_US
dc.subject Antioxidant Potential en_US
dc.subject Behcet'S Disease en_US
dc.subject Lipid Peroxidation en_US
dc.subject Malondialdehyde en_US
dc.title Oxidant/Antioxidant Status in Men With Behcet's Disease en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Atasoy, Mustafa/0000-0003-1904-9878
gdc.author.scopusid 7004499173
gdc.author.scopusid 8240005400
gdc.author.scopusid 56220714100
gdc.author.scopusid 6603760794
gdc.author.scopusid 7005028925
gdc.author.wosid Sari, Refik Ali/Aaw-4221-2021
gdc.author.wosid Akdeniz, Necmettin/J-9325-2013
gdc.author.wosid Taysi, Seyithan/G-6398-2019
gdc.author.wosid Atasoy, Mustafa/D-2679-2014
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp Nenehatun Obstet & Gynecol Hosp, Dept Biochem, Erzurum, Turkey; Ataturk Univ, Sch Med, Dept Biochem, Erzurum, Turkey; Yil Univ 100, Dept Dermatol, Van, Turkey; Ataturk Univ, Sch Med, Dept Dermatol, Erzurum, Turkey; Ataturk Univ, Sch Med, Dept Immunol, Erzurum, Turkey en_US
gdc.description.endpage 422 en_US
gdc.description.issue 3 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q1
gdc.description.startpage 418 en_US
gdc.description.volume 26 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q3
gdc.identifier.pmid 17206395
gdc.identifier.wos WOS:000243969700024
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files